Predictive Oncology Corp (POAI): Earnings per share for the last twelve months

Brandmark of Predictive Oncology Corp (POAI)

The scalability of the Predictive Oncology (POAI) AI platform ensures profit growth with minimal expenditures. The rolling unit profit metric visualizes this trend, where the value -120.86 describes the current level. Business resilience is based on the non-cyclical nature of government medical contracts. Proprietary algorithms and unique biodata databases create a high barrier to entry, protecting the company's market positions.

POAI predictive-oncology.com Net earnings per share for the last four quarters (07/04/2022 - 12/12/2025)

Analytical breakdowns for Predictive Oncology Inc (POAI)

- stock price and consensus target price:
Stock Price Predictive Oncology Corp|POAI - Analyst Median Target
- stock exchange capitalization data:
Market Value Predictive Oncology Inc.|POAI - Business Value
- shareholders' equity book value data:
Net Assets per Single Share Predictive Oncology|POAI - Book Valuation of Business|Market Cap to Net Assets Ratio predictive-oncology.com|POAI - Aggregate Business Assets
- debt burden and liquidity indicators:
Debt to Equity Predictive Oncology|POAI - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio Predictive Oncology Corp|POAI - Company Aggregate Debts|Debt to Book Capitalization Ratio Predictive Oncology Inc.|POAI - Company Long-Term Liabilities|Company Short-Term Debts Predictive Oncology|Quick Liquidity predictive-oncology.com
- earnings and multiples data:
POAI - Company Profit|Future Profit Predictive Oncology|POAI - Market Price to Net Income Ratio|Future Price to Earnings Predictive Oncology Corp|POAI - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Predictive Oncology Inc.|POAI - Profit before deduction of interest, taxes, depreciation and amortization|Earnings per share for the last twelve months Predictive Oncology|POAI - Earnings per share for the trailing year|Quarterly EPS earnings growth predictive-oncology.com|POAI - Earnings per share growth rate in current year|Earnings growth forecast for next year Predictive Oncology
Analysis of all company metrics:POAI - predictive-oncology.com
Mass-produced product of Predictive Oncology

Net income per share (TTM) measures the total specific income over four quarters, adjusted for the total number of securities. This metric captures the real efficiency of the business prior to dividend distribution. By analyzing changes in the rolling net income per share, an investor identifies hidden imbalances between price growth and financial results. For Predictive Oncology (POAI), this indicator reflects the monetization of the CoMet AI platform. A powerful patent barrier should convert into sustainable growth of this metric.

Competitor analysis

Intuitive Surgical - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters danaher.com DHR|Becton Dickinson (BDX) - Earnings per share for the last twelve months|Earnings per share for the last 12 months STE|Earnings per share for the last twelve months West Pharmaceutical Services Inc|Baxter Healthcare (BAX) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months MASI (Masimo Corporation)|Earnings per share for the last four quarters STVN|Earnings per share for the last twelve months Teleflex TFX|Earnings per share for the trailing year MMSI|NVST: Net earnings per share for the last 12 months|ICUI - Net earnings per share (EPS TTM)|DENTSPLY SIRONA Inc. (XRAY) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months lemaitre.com|ATRC (AtriCure) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months STAAR Surgical Co. STAA|Earnings per share for the last twelve months Niagen (NAGE)|ZimVie Corp - Earnings per share for the last 12 months|AngioDynamics, Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters CERS (cerus.com)|TKNO - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Monogram Technologies Inc. MGRM|sharpstechnology.com (STSS) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months INFU (InfuSystem Holdings, Inc.)|Earnings per share for the last twelve months Utah Medical Products|KRMD: Earnings per share for the trailing year|Net earnings per share (EPS TTM) NYXH|MBOT - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) PDEX (Pro-Dex Corp)|ZTEK: Earnings per share for the last 12 months|Elutia Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters milestonescientific.com MLSS|NXGL: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Retractable Technologies, Inc.|Net earnings per share for the last 12 months HBIO|FEMY (Femasys Corporation) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) MHUA|Net earnings per share for the last four quarters callanjmb.com|Atrion - Net earnings per share for the last 12 months|NeuroMetrix Inc - Earnings per share for the last twelve months